Skip to main content
NCBI home page
Neurotherapeutics logoLink to Neurotherapeutics
. 2009 Jan;6(1):94–107. doi: 10.1016/j.nurt.2008.10.038

Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders

Kimberly R Byrnes 1,✉, David J Loane 1, Alan I Faden 1
PMCID: PMC2634659  NIHMSID: NIHMS87070  PMID: 19110202

Summary

Glutamate is a major excitatory neurotransmitter in the CNS that is involved in numerous cellular functions, including cell death and survival. Metabotropic glutamate receptors (mGluR) are G-protein coupled receptors that have been classified into three groups on the basis of signal transduction pathways and pharmacological profiles. Group I, II, and III mGluRs are found on cell types within and peripheral to the CNS, including neurons, microglia, astrocytes, oligodendrocytes, T- and B-cell lymphocytes, osteoblasts, hepatocytes, and endothelial cells, among others. These receptors have a number of effects on cells that can influence outcome after trauma, including reducing neuronal and oligodendroglial cell death, inflammation, and endothelial permeability. Thus, mGluRs are a promising multipotential therapeutic approach. Because the pathology of CNS trauma and neurodegeneration is multifactorial (including, for example, oxidative stress, mitochondrial breakdown, and inflammation), therapies that serve to modulate multiple pathophysiological pathways may prove more effective than those directed at a single target. This review examines the multipotential therapeutic utility of mGluR modulation in acute and chronic injury and neurodegeneration.

Key Words: Astrocytes, inflammation, metabotropic glutamate receptors, microglia, neuron, neuroprotection

References

  • 1.Dingledine R, Borges K, Bowic D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7–61. [PubMed] [Google Scholar]
  • 2.Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci. 2001;21:3771–3779. doi: 10.1523/JNEUROSCI.21-11-03771.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Warwick HK, Nahorski SR, Challiss RA. Group I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to cyclic AMP response element binding protein (CREB) through a common Ca2+- and protein kinase C-dependent pathway. J Neurochem. 2005;93:232–245. doi: 10.1111/j.1471-4159.2005.03012.x. [DOI] [PubMed] [Google Scholar]
  • 4.Demediuk P, Daly MP, Faden AI. Effect of impact trauma on neurotransmitter and nonneurotransmitter amino acids in rat spinal cord. J Neurochem. 1989;52:1529–1536. doi: 10.1111/j.1471-4159.1989.tb09204.x. [DOI] [PubMed] [Google Scholar]
  • 5.Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244:798–800. doi: 10.1126/science.2567056. [DOI] [PubMed] [Google Scholar]
  • 6.Gwak YS, Hulsebosch CE. Upregulation of group I metabotropic glutamate receptors in neurons and astrocytes in the dorsal hom following spinal cord injury. Exp Neurol. 2005;195:236–243. doi: 10.1016/j.expneurol.2005.05.012. [DOI] [PubMed] [Google Scholar]
  • 7.Mills CD, Fullwood SD, Hulsebosch CE. Changes in metabotropic glutamate receptor expression following spinal cord injury. Exp Neurol. 2001;170:244–257. doi: 10.1006/exnr.2001.7721. [DOI] [PubMed] [Google Scholar]
  • 8.Kaiser S, Nisenbaum LK. Evaluation of common gene expression patterns in the rat nervous system. Physiol Genomics. 2003;16:1–7. doi: 10.1152/physiolgenomics.00125.2003. [DOI] [PubMed] [Google Scholar]
  • 9.Morphy R, Rankovic Z. Designed multiple ligands: an emerging drug discovery paradigm. J Med Chem. 2005;48:6523–6543. doi: 10.1021/jm058225d. [DOI] [PubMed] [Google Scholar]
  • 10.Van der Schyf CJ, Mandel S, Geldenhuys WJ, et al. Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties. Curr Alzheimer Res. 2007;4:522–536. doi: 10.2174/156720507783018226. [DOI] [PubMed] [Google Scholar]
  • 11.Faden AI, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol. 2007;64:794–800. doi: 10.1001/archneur.64.6.794. [DOI] [PubMed] [Google Scholar]
  • 12.Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res. 2006;326:483–504. doi: 10.1007/s00441-006-0266-5. [DOI] [PubMed] [Google Scholar]
  • 13.Mudo G, Trovato-Salinaro A, Caniglia G, Cheng Q, Condorelli DF. Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res. 2007;1149:1–13. doi: 10.1016/j.brainres.2007.02.041. [DOI] [PubMed] [Google Scholar]
  • 14.Ure J, Baudry M, Perassolo M. Metabotropic glutamate receptors and epilepsy. J Neurol Sci. 2006;247:1–9. doi: 10.1016/j.jns.2006.03.018. [DOI] [PubMed] [Google Scholar]
  • 15.Zhong J, Gerber G, Kojic L, Randic M. Dual modulation of excitatory synaptic transmission by agonists at group I metabotropic glutamate receptors in the rat spinal dorsal hom. Brain Res. 2000;887:359–377. doi: 10.1016/s0006-8993(00)03066-3. [DOI] [PubMed] [Google Scholar]
  • 16.Bruno V, Copani A, Knöpfel T, et al. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology. 1995;34:1089–1098. doi: 10.1016/0028-3908(95)00077-j. [DOI] [PubMed] [Google Scholar]
  • 17.Allen JW, Knoblach SM, Faden AI. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ. 2000;7:470–476. doi: 10.1038/sj.cdd.4400678. [DOI] [PubMed] [Google Scholar]
  • 18.Allen JW, Vicini S, Faden AI. Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release. Exp Neurol. 2001;169:449–460. doi: 10.1006/exnr.2001.7672. [DOI] [PubMed] [Google Scholar]
  • 19.Sapirstein A, Bonventre JV. Phospholipases A2 in ischemic and toxic brain injury. Neurochem Res. 2000;25:745–753. doi: 10.1023/a:1007583708713. [DOI] [PubMed] [Google Scholar]
  • 20.Faden AI, O’Leary DM, Fan L, Bao W, Mullins PG, Movsesyan VA. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma. Exp Neurol. 2001;167:435–444. doi: 10.1006/exnr.2000.7577. [DOI] [PubMed] [Google Scholar]
  • 21.Mukhin AG, Ivanova SA, Faden AI. mGluR modulation of post-traumatic neuronal death: role of NMDA receptors. Neuroreport. 1997;8:2561–2566. doi: 10.1097/00001756-199707280-00028. [DOI] [PubMed] [Google Scholar]
  • 22.O’Leary DM, Movsesyan V, Vicini S, Faden AI. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol. 2000;131:1429–1437. doi: 10.1038/sj.bjp.0703715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lea PM, Movsesyan VA, Faden AI. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br J Pharmacol. 2005;145:527–534. doi: 10.1038/sj.bjp.0706219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Allen JW, Eldadah BA, Faden AI. β-Amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors. Neuropharmacology. 1999;38:1243–1252. doi: 10.1016/s0028-3908(99)00044-1. [DOI] [PubMed] [Google Scholar]
  • 25.Vincent AM, TenBroeke M, Maiese K. Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH. Exp Neurol. 1999;155:79–94. doi: 10.1006/exnr.1998.6966. [DOI] [PubMed] [Google Scholar]
  • 26.Movsesyan VA, Stoica BA, Faden AI. mGluR5 activation reduces β-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J Neurochem. 2004;89:1528–1536. doi: 10.1111/j.1471-4159.2004.02451.x. [DOI] [PubMed] [Google Scholar]
  • 27.Zhu P, DeCoster MA, Bazan NG. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. J Neurosci Res. 2004;77:525–531. doi: 10.1002/jnr.20175. [DOI] [PubMed] [Google Scholar]
  • 28.Vincent AM, Maiese K. The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death. Exp Neurol. 2000;166:65–82. doi: 10.1006/exnr.2000.7487. [DOI] [PubMed] [Google Scholar]
  • 29.Maiese K, Greenberg R, Boccone L, Swiriduk M. Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats. Neurosci Lett. 1995;194:173–176. doi: 10.1016/0304-3940(95)11753-j. [DOI] [PubMed] [Google Scholar]
  • 30.Bond A, Ragumoorthy N, Monn JA, et al. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia. Neurosci Lett. 1999;273:191–194. doi: 10.1016/s0304-3940(99)00663-1. [DOI] [PubMed] [Google Scholar]
  • 31.Sabelhaus CF, Schroder UH, Bieder J, Henrich-Noack P, Reymann KG. Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine. Br J Pharmacol. 2000;131:655–658. doi: 10.1038/sj.bjp.0703646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Copani A, Bruno V, Battaglia G, et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol. 1995;47:890–897. [PubMed] [Google Scholar]
  • 33.Movsesyan VA, Faden AI. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury. J Neurotrauma. 2006;23:117–127. doi: 10.1089/neu.2006.23.117. [DOI] [PubMed] [Google Scholar]
  • 34.Allen JW, Ivanova SA, Fan L, Espey MG, Basile AS, Faden AI. Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J Pharmacol Exp Ther. 1999;290:112–120. [PubMed] [Google Scholar]
  • 35.Faden AI, Ivanova SA, Yakovlev AG, Mukhin AG. Neuroprotective effects of group III mGluR in traumatic neuronal injury. J Neurotrauma. 1997;14:885–895. doi: 10.1089/neu.1997.14.885. [DOI] [PubMed] [Google Scholar]
  • 36.Biber K, Lauric DJ, Berthele A, et al. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem. 1999;72:1671–1680. doi: 10.1046/j.1471-4159.1999.721671.x. [DOI] [PubMed] [Google Scholar]
  • 37.Geurts JJ, Wolswijk G, Bö L, et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain. 2003;126:1755–1766. doi: 10.1093/brain/awg179. [DOI] [PubMed] [Google Scholar]
  • 38.Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden AI. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2008 Sep 24 [Epub ahead of print]. [DOI] [PMC free article] [PubMed]
  • 39.Taylor DL, Diemel LT, Cuzner ML, Pocock JM. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer’s disease. J Neurochem. 2002;82:1179–1191. doi: 10.1046/j.1471-4159.2002.01062.x. [DOI] [PubMed] [Google Scholar]
  • 40.Pinteaux-Jones F, Sevastou IG, Fry VA, Heales S, Baker D, Pocock JM. Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J Neurochem. 2008;106:442–454. doi: 10.1111/j.1471-4159.2008.05426.x. [DOI] [PubMed] [Google Scholar]
  • 41.Taylor DL, Diemel LT, Pocock JM. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci. 2003;23:2150–2160. doi: 10.1523/JNEUROSCI.23-06-02150.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Geurts JJ, Wolswijk G, Bö L, et al. Expression patterns of group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J Neuroimmunol. 2005;158:182–190. doi: 10.1016/j.jneuroim.2004.08.012. [DOI] [PubMed] [Google Scholar]
  • 43.Schools GP, Kimelberg HK. mGluR3 and mGluR5 aic the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats. J Neurosci Res. 1999;58:533–543. doi: 10.1002/(sici)1097-4547(19991115)58:4<533::aid-jnr6>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 44.Cai Z, Schools GP, Kimelberg HK. Metabotropic glutamate receptors in acutely isolated hippocampal astrocytes: developmental changes of mGluR5 mRNA and functional expression. Glia. 2000;29:70–80. doi: 10.1002/(sici)1098-1136(20000101)29:1<70::aid-glia7>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  • 45.Romano C, Sesma MA, McDonald CT, O’Malley K, Van den Pol AN, Olney JW. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol. 1995;355:455–469. doi: 10.1002/cne.903550310. [DOI] [PubMed] [Google Scholar]
  • 46.Balázs R, Miller S, Romano C, de Vries A, Chun Y, Cotman CW. Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation. J Neurochem. 1997;69:151–163. doi: 10.1046/j.1471-4159.1997.69010151.x. [DOI] [PubMed] [Google Scholar]
  • 47.Condorelli DF, Dell’Albani P, Amico C, et al. Development profile of metabotropic glutamate receptor mRNA in rat brain. Mol Pharmacol. 1992;41:660–664. [PubMed] [Google Scholar]
  • 48.Miller S, Romano C, Cotman CW. Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J Neurosci. 1995;15:6103–6109. doi: 10.1523/JNEUROSCI.15-09-06103.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Silva GA, Theriault E, Mills LR, Pennefather PS, Feeney CJ. Group I and II metabotropic glutamate receptor expression in cultured rat spinal cord astrocytes. Neurosci Lett. 1999;263:117–120. doi: 10.1016/s0304-3940(99)00145-7. [DOI] [PubMed] [Google Scholar]
  • 50.Aronica E, Catania MV, Geurts J, Yankaya B, Troost D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience. 2001;105:509–520. doi: 10.1016/s0306-4522(01)00181-6. [DOI] [PubMed] [Google Scholar]
  • 51.Aronica E, van Vliet EA, Mayboroda OA, Troost D, da Silva FH, Goiter JA. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci. 2000;12:2333–2344. doi: 10.1046/j.1460-9568.2000.00131.x. [DOI] [PubMed] [Google Scholar]
  • 52.Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res. 2001;137:1–11. doi: 10.1007/s002210000633. [DOI] [PubMed] [Google Scholar]
  • 53.Ulas J, Satou T, Ivins KJ, Kesslak JP, Cotman CW, Balázs R. Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia. 2000;30:352–361. [PubMed] [Google Scholar]
  • 54.Nakahara K, Okada M, Nakanishi S. The metabotropic glutamate receptor mGluR5 induces calcium oscillations in cultured astrocytes via protein kinase C phosphorylation. J Neurochem. 1997;69:1467–1475. doi: 10.1046/j.1471-4159.1997.69041467.x. [DOI] [PubMed] [Google Scholar]
  • 55.Pasti L, Volterra A, Pozzan T, Carmignoto G. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci. 1997;17:7817–7830. doi: 10.1523/JNEUROSCI.17-20-07817.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Peavy RD, Conn PJ. Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors. J Neurochem. 1998;71:603–612. doi: 10.1046/j.1471-4159.1998.71020603.x. [DOI] [PubMed] [Google Scholar]
  • 57.Servitja JM, Masgrau R, Sarri E, Picatoste F. Group I metabotropic glutamate receptors mediate phospholipase D stimulation in rat cultured astrocytes. J Neurochem. 1999;72:1441–1447. doi: 10.1046/j.1471-4159.1999.721441.x. [DOI] [PubMed] [Google Scholar]
  • 58.Ohishi H, Neki A, Mizuno N. Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody. Neurosci Res. 1998;30:65–82. doi: 10.1016/s0168-0102(97)00120-x. [DOI] [PubMed] [Google Scholar]
  • 59.Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience. 1996;71:949–976. doi: 10.1016/0306-4522(95)00533-1. [DOI] [PubMed] [Google Scholar]
  • 60.Aronica E, Goiter JA, IJlst-Keizers H, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci. 2003;17:2106–2118. doi: 10.1046/j.1460-9568.2003.02657.x. [DOI] [PubMed] [Google Scholar]
  • 61.Ciccarelli R, Sureda FX, Casabona G, et al. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia. 1997;21:390–398. doi: 10.1002/(sici)1098-1136(199712)21:4<390::aid-glia6>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  • 62.Moldrich RX, Aprico K, Diwakarla S, O’Shea RD, Beart PM. Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology. 2002;43:189–203. doi: 10.1016/s0028-3908(02)00111-9. [DOI] [PubMed] [Google Scholar]
  • 63.Winder DG, Ritch PS, Gereau RW, Conn PJ. Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus. J Physiol. 1996;494:743–755. doi: 10.1113/jphysiol.1996.sp021529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.D’Onofrio M, Cuomo L, Battaglia G, et al. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem. 2001;78:435–445. doi: 10.1046/j.1471-4159.2001.00435.x. [DOI] [PubMed] [Google Scholar]
  • 65.Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β. J Neurosci. 1998;18:9594–9600. doi: 10.1523/JNEUROSCI.18-23-09594.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Ciccarelli R, D’Alimonte I, Ballerini P, et al. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes. Mol Pharmacol. 2007;71:1369–1380. doi: 10.1124/mol.106.031617. [DOI] [PubMed] [Google Scholar]
  • 67.Besong G, Battaglia G, D’Onofrio M, et al. Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures. J Neurosci. 2002;22:5403–5411. doi: 10.1523/JNEUROSCI.22-13-05403.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Maiese K, Chong ZZ, Li F. Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr Neurovasc Res. 2005;2:425–446. doi: 10.2174/156720205774962692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A. 2004;101:7751–7756. doi: 10.1073/pnas.0307850101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Luyt K, Varadi A, Halfpenny CA, Scolding NJ, Molnar E. Metabotropic glutamate receptors are expressed in adult human glial progenitor cells. Biochem Biophys Res Commun. 2004;319:120–129. doi: 10.1016/j.bbrc.2004.04.158. [DOI] [PubMed] [Google Scholar]
  • 71.Luyt K, Varadi A, Molnar E. Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells. J Neurochem. 2003;84:1452–1464. doi: 10.1046/j.1471-4159.2003.01661.x. [DOI] [PubMed] [Google Scholar]
  • 72.Pacheco R, Ciruela F, Casadó V, et al. Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem. 2004;279:33352–33358. doi: 10.1074/jbc.M401761200. [DOI] [PubMed] [Google Scholar]
  • 73.Boldyrev AA, Carpenter DO, Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem. 2005;95:913–918. doi: 10.1111/j.1471-4159.2005.03456.x. [DOI] [PubMed] [Google Scholar]
  • 74.Benarroch EE. Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease. Neurology. 2008;70:964–968. doi: 10.1212/01.wnl.0000306315.03021.2a. [DOI] [PubMed] [Google Scholar]
  • 75.Mills CD, Johnson KM, Hulsebosch CE. Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain. J Neurotrauma. 2002;19:23–42. doi: 10.1089/089771502753460213. [DOI] [PubMed] [Google Scholar]
  • 76.Lyeth BG, Gong QZ, Shields S, Muizelaar JP, Berman RF. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats. Exp Neurol. 2001;169:191–199. doi: 10.1006/exnr.2001.7643. [DOI] [PubMed] [Google Scholar]
  • 77.Kohara A, Takahashi M, Yatsugi S, et al. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models. Brain Res. 2008;1191:168–179. doi: 10.1016/j.brainres.2007.11.035. [DOI] [PubMed] [Google Scholar]
  • 78.Topolnik L, Azzi M, Morin F, Kougioumoutzakis A, Lacaille JC. mGluR1/5 subtype-specific calcium signalling and induction of long-term potentiation in rat hippocampal oriens/alveus intemeurones. J Physiol. 2006;575:115–131. doi: 10.1113/jphysiol.2006.112896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Eder C. Ion channels in microglia (brain macrophages) Am J Physiol. 1998;275:C327–C342. doi: 10.1152/ajpcell.1998.275.2.C327. [DOI] [PubMed] [Google Scholar]
  • 80.Lea PM, Custer SJ, Vicini S, Faden AI. Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol Biochem Behav. 2002;73:2106–2118. doi: 10.1016/s0091-3057(02)00825-0. [DOI] [PubMed] [Google Scholar]
  • 81.Bao WL, Williams AJ, Faden AI, Tortella FC. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 2001;922:173–179. doi: 10.1016/s0006-8993(01)03062-1. [DOI] [PubMed] [Google Scholar]
  • 82.Vernon AC, Zbarsky V, Datla KP, Croucher MJ, Dexter DT. Subtype selective antagonism of substantia nigra pars compacta group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. J Neurochem. 2007;103:1075–1091. doi: 10.1111/j.1471-4159.2007.04860.x. [DOI] [PubMed] [Google Scholar]
  • 83.Pinheiro PS, Mulle C. Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nat Rev Neurosci. 2008;9:423–436. doi: 10.1038/nrn2379. [DOI] [PubMed] [Google Scholar]
  • 84.Venero JL, Santiago M, Tomás-Camardiel M, Matarredona ER, Cano J, Machado A. DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum: correlation with neuronal injury. Neuroscience. 2002;113:857–869. doi: 10.1016/s0306-4522(02)00232-4. [DOI] [PubMed] [Google Scholar]
  • 85.Matarredona ER, Santiago M, Venero JL, Cano J, Machado A. Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction. J Neurochem. 2001;76:351–360. doi: 10.1046/j.1471-4159.2001.00056.x. [DOI] [PubMed] [Google Scholar]
  • 86.Mills CD, Johnson KM, Hulsebosch CE. Role of group II and group III metabotropic glutamate receptors in spinal cord injury. Exp Neurol. 2002;173:153–167. doi: 10.1006/exnr.2001.7828. [DOI] [PubMed] [Google Scholar]
  • 87.Bruno V, Battaglia G, Ksiazek I, et al. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. J Neurosci. 2000;20:6413–6420. doi: 10.1523/JNEUROSCI.20-17-06413.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Zhong C, Zhao X, Sarva J, Kozikowski A, Neale JH, Lyeth BG. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats. J Neurotrauma. 2005;22:266–276. doi: 10.1089/neu.2005.22.266. [DOI] [PubMed] [Google Scholar]
  • 89.Lee HG, Zhu X, O’Neill MJ, et al. The role of metabotropic glutamate receptors in Alzheimer’s disease. Acta Neurobiol Exp (Wars) 2004;64:89–98. doi: 10.55782/ane-2004-1494. [DOI] [PubMed] [Google Scholar]
  • 90.Rouse ST, Marino MJ, Bradley SR, Awad H, Wittmann M, Conn PJ. Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson’s disease and related disorders. Pharmacol Ther. 2000;88:427–435. doi: 10.1016/s0163-7258(00)00098-x. [DOI] [PubMed] [Google Scholar]
  • 91.Bradley SR, Marino MJ, Wittmann M, et al. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata. J Neurosci. 2000;20:3085–3094. doi: 10.1523/JNEUROSCI.20-09-03085.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Byrnes KR, Garay J, Di Giovanni S, et al. Expression of two temporally distinct microglia-related gene clusters after spinal cord injury. Glia. 2006;53:420–433. doi: 10.1002/glia.20295. [DOI] [PubMed] [Google Scholar]
  • 93.Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem. 2008;51:347–372. doi: 10.1021/jm7009364. [DOI] [PubMed] [Google Scholar]
  • 94.Verkhratsky A, Kirchhoff F. Glutamate-mediated neuronal-glial transmission. J Anat. 2007;210:651–660. doi: 10.1111/j.1469-7580.2007.00734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Rezzani R, Corsetti G, Rodella L, Angoscini P, Lonati C, Bianchi R. Cyclosporine-A treatment inhibits the expression of metabotropic glutamate receptors in rat thymus. Acta Histochem. 2003;105:81–87. doi: 10.1078/0065-1281-00688. [DOI] [PubMed] [Google Scholar]
  • 96.Storto M, de Grazia U, Knöpfel T, et al. Selective blockade of mGlu5 metabotropic glutamate receptors protects rat hepatocytes against hypoxic damage. Hepatology. 2000;31:649–655. doi: 10.1002/hep.510310315. [DOI] [PubMed] [Google Scholar]
  • 97.Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, Chen S. Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res. 2008;21:368–378. doi: 10.1111/j.1755-148X.2008.00452.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Frati C, Marchese C, Fisichella G, et al. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J Cell Physiol. 2000;183:364–372. doi: 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  • 99.Luyt K, Varadi A, Durant CF, Molnar E. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem. 2006;10:651–660. doi: 10.1111/j.1471-4159.2006.04103.x. [DOI] [PubMed] [Google Scholar]
  • 100.Collard CD, Park KA, Montalto MC, et al. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem. 2002;277:14801–14811. doi: 10.1074/jbc.M110557200. [DOI] [PubMed] [Google Scholar]
  • 101.Yao HH, Ding JH, Zhou F, et al. Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes. J Neurochem. 2005;92:948–961. doi: 10.1111/j.1471-4159.2004.02937.x. [DOI] [PubMed] [Google Scholar]
  • 102.Hinoi E, Fujimori S, Nakamura Y, Yoneda Y. Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem Biophys Res Commun. 2001;281:341–346. doi: 10.1006/bbrc.2001.4355. [DOI] [PubMed] [Google Scholar]
  • 103.Foreman MA, Gu Y, Howl JD, Jones S, Publicover SJ. Group III metabotropic glutamate receptor activation inhibits Ca2+ influx and nitric oxide synthase activity in bone marrow stromal cells. J Cell Physiol. 2005;204:704–713. doi: 10.1002/jcp.20353. [DOI] [PubMed] [Google Scholar]

Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES